Skip to main content
. 2016 Jun 10;95(23):e3738. doi: 10.1097/MD.0000000000003738

Figure 1.

Figure 1

CD4+ T-cell counts and CD4+/CD8+ ratio in the blood of individuals treated during primary (EA) and chronic (LA) phases of HIV-1 infection. CD4+ T-cell counts (cells/μL) and the ratio between CD4+ T cells and CD8+ T cells (CD4+/CD8+ ratio) were measured in the blood of subjects belonging to both EA (n = 17) and LA (n = 17) study groups. The measurements were performed before ART initiation (baseline [BL]), at 12 months (12 m) after ART and at sampling (S). The statistical difference in the values between the time points was calculated using ANOVA. Median values are shown in the figures. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001, and ∗∗∗∗P < 0.0001. ANOVA, analysis of variance; ART, antiretroviral therapy; EA, early ART; LA, late ART.